Fig. 4
- ID
- ZDB-FIG-240906-4
- Publication
- Wang et al., 2024 - Inhibition of mitochondrial citrate shuttle alleviates metabolic syndromes induced by high-fat diet
- Other Figures
- All Figure Page
- Back to All Figure Page
Slc25a1 inhibition attenuates high-fat diet (HFD)-induced abnormal hepatic lipid deposition by enhancing oxidative catabolism. A: hepatic triglyceride(TAG) content in zebrafish (n = 6). B: hepatic nonesterified fatty acid (NEFA) content in zebrafish (n = 6). C–F: mRNA expression of hepatic liposynthesis- and lipid catabolism-related genes in zebrafish (n = 5–7). G and I: protein expression of hepatic carnitine palmitoyltransferase 1a (Cpt1a) in zebrafish and Nile tilapia (n = 2–3). H: hepatic TAG content in Nile tilapia (n = 6). J and K: rate of [1-14C]- palmitic acid (PA) oxidation in vitro and in vivo (n = 3 and 6, respectively). L: lipid metabolism patterns after inhibition of Slc25a1 under HFD. Values are means ± SD. The asterisk symbol indicates significant differences from the control treatment at *P < 0.05, **P < 0.01, ***P < 0.001 (independent-sample t test). Figure created with BioRender.com. |